13.32
price up icon3.99%   0.5394
 
loading

Vor Biopharma Inc Borsa (VOR) Ultime notizie

pulisher
08:36 AM

Vor Biopharma (VOR) Receives New 'Buy' Rating From Citigroup | V - GuruFocus

08:36 AM
pulisher
08:35 AM

Citigroup Begins Coverage on Vor Biopharma (NASDAQ:VOR) - MarketBeat

08:35 AM
pulisher
06:01 AM

Citi Starts Vor Biopharma, Inc. (VOR) at Buy - StreetInsider

06:01 AM
pulisher
12:58 PM

How Vor Biopharma Inc. stock responds to policy changes2025 EndofYear Setup & Growth Focused Investment Plans - ulpravda.ru

12:58 PM
pulisher
Jan 08, 2026

Will Vor Biopharma Inc. stock return to pre crisis levelsMarket Sentiment Report & Community Consensus Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How Vor Biopharma Inc. stock valuations compare to rivals2025 Year in Review & High Accuracy Swing Entry Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why Vor Biopharma Inc. stock remains a top recommendationTrade Volume Report & Stock Timing and Entry Methods - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why Vor Biopharma Inc. stock is a must watch in 2025Market Rally & Stepwise Entry and Exit Trade Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How Vor Biopharma Inc. stock benefits from global expansionMonthly Performance Summary & Start Small. End Wealthy. - bollywoodhelpline.com

Jan 08, 2026
pulisher
Jan 06, 2026

Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference - MarketScreener

Jan 06, 2026
pulisher
Jan 04, 2026

What drives Vor Biopharma Inc stock priceInstitutional Buying Trends & Low Entry Cost Trading - earlytimes.in

Jan 04, 2026
pulisher
Jan 04, 2026

Ariose Capital Management Ltd Invests $5.37 Million in Vor Biopharma Inc. $VOR - MarketBeat

Jan 04, 2026
pulisher
Jan 03, 2026

Vor Biopharma Inc Stock Analysis and ForecastSell Signals and Alerts & Free High Yield Growth Strategies - earlytimes.in

Jan 03, 2026
pulisher
Jan 02, 2026

Aug Macro: Will Vor Biopharma Inc stock outperform international peersFed Meeting & Verified Momentum Stock Watchlist - moha.gov.vn

Jan 02, 2026
pulisher
Jan 02, 2026

Vor Biopharma CDO Departs, Transition Support Planned - TipRanks

Jan 02, 2026
pulisher
Jan 02, 2026

Vor Biopharma Target of Unusually High Options Trading (NASDAQ:VOR) - MarketBeat

Jan 02, 2026
pulisher
Jan 02, 2026

Portfolio Update: How Vor Biopharma Inc. stock benefits from global expansionTrade Risk Report & Fast Entry and Exit Trade Plans - moha.gov.vn

Jan 02, 2026
pulisher
Dec 31, 2025

Vor Biopharma (VOR) Stock Jumps Over 30% After JPMorgan Upgrade: What December 2025’s Rally Really Means for Investors - ts2.tech

Dec 31, 2025
pulisher
Dec 29, 2025

Gap Down: Is Vor Biopharma Inc stock positioned well for digital economyJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - moha.gov.vn

Dec 29, 2025
pulisher
Dec 28, 2025

Vor Biopharma (VOR) Stock Analysis Report | Financials & Insights - Benzinga

Dec 28, 2025
pulisher
Dec 27, 2025

Vor Biopharma Inc. (NASDAQ:VOR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 27, 2025
pulisher
Dec 25, 2025

Moving Averages: How strong is Celsius Holdings Inc stock balance sheet2025 Short Interest & Community Verified Swing Trade Signals - moha.gov.vn

Dec 25, 2025
pulisher
Dec 25, 2025

Vor Biopharma Stock (+7.4%): New Board Signals Institutional Backing - Trefis

Dec 25, 2025
pulisher
Dec 24, 2025

Vor Biopharma Inc. (NASDAQ:VOR) Sees Large Growth in Short Interest - MarketBeat

Dec 24, 2025
pulisher
Dec 23, 2025

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors - The Globe and Mail

Dec 23, 2025
pulisher
Dec 23, 2025

Vor Biopharma adds two investment partners to board of directors By Investing.com - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 23, 2025

Vor Biopharma Inc Announces Board Appointments - marketscreener.com

Dec 23, 2025
pulisher
Dec 21, 2025

Vor Biopharma Inc.(NasdaqGS: VOR) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 21, 2025
pulisher
Dec 19, 2025

VOR: JP Morgan Lowers Price Target While Maintaining Overweight Rating | VOR Stock News - GuruFocus

Dec 19, 2025
pulisher
Dec 19, 2025

JPMorgan Chase & Co. Issues Pessimistic Forecast for Vor Biopharma (NASDAQ:VOR) Stock Price - MarketBeat

Dec 19, 2025
pulisher
Dec 18, 2025

Why Vor Biopharma Inc. stock appeals to dividend seekersJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - ulpravda.ru

Dec 18, 2025
pulisher
Dec 18, 2025

Vor Biopharma Signs Multiple Financing Agreements - TradingView — Track All Markets

Dec 18, 2025
pulisher
Dec 18, 2025

Vor Biopharma (VOR) secures $150M private placement and adds two directors - Stock Titan

Dec 18, 2025
pulisher
Dec 18, 2025

Technical Analysis: Will Vor Biopharma Inc. stock reach all time highs in 2025Earnings Performance Report & Accurate Technical Buy Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Vor Biopharma shares rise after collaborator’s IgAN therapy meets Phase 3 endpoint - MSN

Dec 18, 2025
pulisher
Dec 17, 2025

Vor Biopharma: Initiating Hold Rating On Durable Telitacicept MG Study Data - Seeking Alpha

Dec 17, 2025
pulisher
Dec 17, 2025

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential By Investing.com - Investing.com South Africa

Dec 17, 2025
pulisher
Dec 17, 2025

VOR: TD Cowen Initiates Coverage with a 'Buy' Rating | VOR Stock News - GuruFocus

Dec 17, 2025
pulisher
Dec 17, 2025

Vor Biopharma (NASDAQ:VOR) Earns Buy Rating from Analysts at TD Cowen - MarketBeat

Dec 17, 2025
pulisher
Dec 17, 2025

Stocks to watch: Vor Biopharma sees RS rating jump to 89 - MSN

Dec 17, 2025
pulisher
Dec 17, 2025

TD Cowen Initiates Vor Biopharma at Buy - marketscreener.com

Dec 17, 2025
pulisher
Dec 17, 2025

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential - Investing.com Australia

Dec 17, 2025
pulisher
Dec 17, 2025

TD Cowen Starts Vor Biopharma, Inc. (VOR) at Buy - StreetInsider

Dec 17, 2025
pulisher
Dec 16, 2025

Vor Biopharma’s Surge: New Opportunities? - StocksToTrade

Dec 16, 2025
$106.94
price up icon 1.01%
$34.26
price up icon 1.85%
$111.07
price up icon 3.42%
$100.03
price up icon 1.17%
$174.15
price up icon 2.32%
biotechnology ONC
$337.72
price up icon 5.47%
Capitalizzazione:     |  Volume (24 ore):